Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
A novel pancreatic lipase inhibitor for the treatment of obesity in both diabetic and non-diabetic patients.
Yamada, Y. et al.: Horm. Metab. Res., 40, 539 (2008); Kopelman, P. et al.: Int. J. Obes., 31, 494 (2007); Kopelman, P. et al.: Obesity, 18, 108 (2010);
400-821-0725
沪ICP备17019645号
